We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cheaper Genome Mapping on the Way

By Biotechdaily staff writers
Posted on 23 Aug 2005
Researchers have used off-the-shelf instruments and chemical reagents to create a DNA sequencing method that may dramatically reduce the cost of genome mapping.

Investigators at Harvard Medical School (Boston, MA, USA) have converted a commonly available, inexpensive epifluorescence microscope into an automatic non-electrophoretic DNA sequencing instrument. The microscope with attached digital camera and associated computers was used to retrieve data that were generated by a cell-free, mate-paired library that provided single DNA molecules that were amplified in parallel to one-micrometer beads by emulsion PCR (polymerase chain reaction). Millions of gene fragments were immobilized in a polyacrylamide gel and subjected to automated cycles of sequencing and four-color imaging. Fluorescing DNA nucleotides were detected by the microscope's camera, and the results were sent to computers that reinterpreted the data as a linear sequence of base pairs.

Today it costs more than U.S.$20 million dollars to map a complete human genome. Using the new method, as described in the August 4, 2005, online edition of Science, the price can be reduced to about $2.2 million. The authors believe that in the near future this cost can be reduced to as little at $1,000, which would bring genome mapping into the realm of clinical diagnostics. Senior author Dr. George Church, professor of genetics at Harvard Medical School, said, "The cost of $1,000 for a human genome should allow prioritization of detailed diagnostics and therapeutics, as is already happening with cancer.”




Related Links:
Harvard Medical School

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
23 Aug 2005  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
23 Aug 2005  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
23 Aug 2005  |   BioResearch